Lftd Partners Inc. (LIFD): Total Liabilities
$6.64M
As of 2025-12-31
$5.00M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.64M | -34.4% | 2026-04-01, Balance as of period end |
| 2024-12-31 | $10.12M | n/c | 2026-04-01, Balance as of period end |
| 2023-12-31 | $12.53M | +90.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $6.59M | -44.8% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $11.96M | +92.6% | 2023-03-21, Balance as of period end |
| 2020-12-31 | $6.21M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | $189.2K | n/a | 2021-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $41.92M | +370.4% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $18.08M | +2.4% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $112.27M | -16.7% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $119.41M | +123.3% |
Compare LIFD, SBFM, BGM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗